David Schaer

3.7k citations
34 papers · 3k · 1 hit paper · h-index 19

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
  • Immunology top 2%
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune cells in cancer

Papers in

    • Cancer Immunotherapy and Biomarkers 21
    • T-cell and B-cell Immunology 8
    • Immune cells in cancer 2
    • Immunotherapy and Immune Responses 2

David Schaer

34 papers receiving 2.9k citations

David Schaer's Hit Papers

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma 2011 · 561 citations
5610+5+10Years since publication100200300400500

Peers

David Schaer
Comparison fields: 5 of 83
  • Oncology 1.4k
  • Immunology 808
  • Biomaterials 294
  • Radiology, Nuclear Medicine and Imaging 169
  • Pulmonary and Respiratory Medicine 235
Replace Andita Newton with:
Andita Newton United States
Albert Lo United States
Tom A. Groothuis Netherlands
Sean P. Arlauckas United States
Julie S. Lau United States
Bizhi Shi China
Eric E. Gardner United States
Todd D. Armstrong United States
Michael F. Cuccarese United States
Mariangela Figini Italy
David Schaer relative to Andita Newton United States Andita Newton's profile →
Citations per field
00.5×1.7×
Andita Newton · 1×
Citations per year

Countries citing papers authored by David Schaer

Since Specialization
Citations

This map shows the geographic impact of David Schaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Schaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Schaer more than expected).

Fields of papers citing papers by David Schaer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Schaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Schaer. The network helps show where David Schaer may publish in the future.

Co-authors

The 25 scholars most cited alongside David Schaer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Schaer Line = papers co-authored together David Schaer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
Hit paper breakdown →
2011561
2 2018370
3 2018288
4 2010220
5 2019197
6 2013139
7 2001133
8 2017125
9 2013122
10 2012121
11 2019114
12 201499
13 200095
14 200569
15 201669
16 202059
17
Anti-GITR antibodies--potential clinical applications for tumor immunotherapy.
201034
18 200632
19 201025
20 201819

About David Schaer

David Schaer is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Biophysics, having authored 34 papers that have together received 3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), T-cell and B-cell Immunology (8 papers), Immune cells in cancer (2 papers), TGF-β signaling in diseases (2 papers), Immunotherapy and Immune Responses (2 papers), Optical Imaging and Spectroscopy Techniques (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (1.4k citations), Immunology (808 citations), Biomaterials (294 citations), Radiology, Nuclear Medicine and Imaging (169 citations) and Pulmonary and Respiratory Medicine (235 citations). David Schaer has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Jedd D. Wolchok, Taha Merghoub, Daniel Hirschhorn-Cymerman, Michael D. Kalos, Mythili Koneru, Adam D. Cohen, Alan B. Frey, Alan N. Houghton, Michelle S. Bradbury and Oula Peñate Medina. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, PLoS ONE, The Journal of Immunology, Clinical Cancer Research and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact